Trudeau vague on scope of national pharmacare plan

9 December 2019 - New Democratic Party leader Jagmeet Singh says he can’t support the Liberal government’s Speech from the ...

Read more →

Innovative Medicines Canada bans members from paying doctors fees for IV infusions

11 December 2019 - Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous ...

Read more →

National pharmacare must come, even if some provincial governments are against it

10 December 2019 - Naysaying premiers were not elected because they opposed national pharmacare in the last round of provincial elections, ...

Read more →

Pickering mom fights for life-changing CF medicine to come to Canada

10 December 2019 - Stephanie Stavros feels like she's 'screaming into an abyss' as her life slips away. ...

Read more →

Pharmacare with no new medicines

10 December 2019 - Meeting with pricing officials shows that government's true goal is to slash prices so low that no ...

Read more →

AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance for Skyrizi (risankizumab) for the treatment of moderate to severe plaque psoriasis

6 December 2019 - In May 2019 , Skyrizi received positive reimbursement recommendations from the Canadian Agency for Drugs and Technologies ...

Read more →

B.C. wants federal health funding lift before national pharmacare program

3 December 2019 - B.C. wants more money from Ottawa for health care before a national pharmacare program is created, ...

Read more →

Premiers want Ottawa to allow opt out for proposed Pharmacare plan

2 December 2019 - Canada's premiers say they want the federal government to increase health-care transfer funds by just over ...

Read more →

Family asking for help to purchase 'the most expensive drug in the world'

1 December 2019 - Ricardo Batista is desperately hoping for a cure for SMA, for his daughter Eva. ...

Read more →

The ‘Top 10’ challenges for health technology assessment: INAHTA viewpoint

28 November 2019 - The International Network of Agencies for Health Technology Assessment (INAHTA) spans the globe as a network of ...

Read more →

Takhzyro (lanadelumab injection) receives positive recommendation from CADTH's Canadian Drug Expert Committee for the routine prevention of hereditary angioedema attacks

22 November 2019 - The positive recommendation is supported by the recently released findings of the Phase 3 Help Study™ Open-Label ...

Read more →

Proposed Ontario drug regulation changes worry policy experts

22 November 2019 - The Ontario government is proposing drug regulation changes that it says will remove red tape and ...

Read more →

Santen receives CADTH Canadian Drug Expert Committee reimbursement recommendation for Verkazia (cyclosporin 0.1%) eye drops

22 November 2019 - Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee ...

Read more →

Revised process for cell and gene therapies

21 November 2019 - CADTH has undertaken an internal review and established a novel process for the review of cell and ...

Read more →

Ontario and Quebec provide reimbursement for HIV therapies Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate)

18 November 2019 - For more than 30 years, Merck has been committed to scientific research and discovery in HIV that ...

Read more →